UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 434

Sortiert nach

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Annals of oncology, 2013-03, Vol.24 (3), p.640-647

2013

Volltextzugriff (PDF)

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Annals of oncology, 2014-02, Vol.25 (2), p.339-345

2014

Volltextzugriff (PDF)

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of oncology, 2015-02, Vol.26 (2), p.313-320

2015

Volltextzugriff (PDF)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

The Lancet (British edition), 2012-02, Vol.379 (9814), p.432-444

2012

Volltextzugriff (PDF)

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

British journal of cancer, 2013-12, Vol.109 (12), p.2959-2964

2013

Volltextzugriff (PDF)

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

The Lancet (British edition), 2007-05, Vol.369 (9574), p.1711-1723

2007

Volltextzugriff (PDF)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of oncology, 2015-08, Vol.26 (8), p.1685-1691

2015

Volltextzugriff (PDF)

Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma

British journal of surgery, 2009-08, Vol.96 (8), p.919-925

2009

Volltextzugriff (PDF)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

British journal of cancer, 2013-08, Vol.109 (3), p.589-596

2013

Volltextzugriff (PDF)

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Breast (Edinburgh), 2023-04, Vol.68, p.S123-S124

2023

Volltextzugriff (PDF)

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Annals of oncology, 2014-02, Vol.25 (2), p.366-371

2014

Volltextzugriff (PDF)

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer

British journal of cancer, 2014-08, Vol.111 (5), p.837-842

2014

Volltextzugriff (PDF)

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer

Breast (Edinburgh), 2019-08, Vol.46, p.101-107

2019

Volltextzugriff (PDF)

VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival

Surgery, 2006-06, Vol.139 (6), p.839-846

2006

Volltextzugriff (PDF)

ONCOPOOL – A European database for 16,944 cases of breast cancer

European journal of cancer (1990), 2010-01, Vol.46 (1), p.56-71

2010

Volltextzugriff (PDF)

Long-term outcomes after endothoracic sympathetic block at the T4 ganglion for upper limb hyperhidrosis

British journal of surgery, 2013-10, Vol.100 (11), p.1471-1477

2013

Volltextzugriff (PDF)

An update on ovarian suppression/ablation

International journal of gynecological cancer, 2006-09, Vol.16 (s2), p.511-514

JAKESZ, R.

2006

Volltextzugriff (PDF)

HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer

Annals of oncology, 2010-05, Vol.21 (5), p.955-960

2010

Volltextzugriff (PDF)

Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer

European journal of surgical oncology, 2009-03, Vol.35 (3), p.264-270

2009

Volltextzugriff (PDF)

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

British journal of cancer, 2007-10, Vol.97 (8), p.1021-1027

2007

Volltextzugriff (PDF)

The use of a breast symmetry index for objective evaluation of breast cosmesis

Breast (Edinburgh), 2007-08, Vol.16 (4), p.429-435

2007

Volltextzugriff (PDF)

Improved quality of life after sympathetic block for upper limb hyperhidrosis

British journal of surgery, 2006-05, Vol.93 (5), p.582-586

2006

Volltextzugriff (PDF)

Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study

Breast cancer research and treatment, 2011-05, Vol.127 (1), p.121-128

2011

Volltextzugriff (PDF)

Efficacy of tamoxifen + aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

British journal of cancer, 2013-04, Vol.108 (7), p.1408-1414

2013

Volltextzugriff (PDF)

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial

Annals of oncology, 2013-05, Vol.24 (5), p.1203-1211

2013

Volltextzugriff (PDF)

1 – 25 von 434

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(360)

Publikationsform

Artikel
(428)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Surgery
(33)
European Journal Of Cancer
(29)
Journal Of Clinical Oncology
(26)
Cancer Research
(24)
Breast
(20)
Wiener Klinische Wochenschrift
(19)
Acta Chirurgica Austriaca
(16)
Chirurg
(16)
Breast Cancer Research And Treatment
(14)
The Lancet
(14)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer

VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival

ONCOPOOL – A European database for 16,944 cases of breast cancer

Long-term outcomes after endothoracic sympathetic block at the T4 ganglion for upper limb hyperhidrosis

An update on ovarian suppression/ablation

HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer

Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

The use of a breast symmetry index for objective evaluation of breast cosmesis

Improved quality of life after sympathetic block for upper limb hyperhidrosis

Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study

Efficacy of tamoxifen + aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial

Suchergebnisse filtern